Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Razoxane is a racemic mixture of dexrazoxane (Item No. 14632) and levrazoxane.1 Unlike dexrazoxane, razoxane inhibits topoisomerase II-α (TOP2A) and TOP2B only weakly (IC50s = 301 and 505 µM, respectively). Razoxane slows tumor growth, normalizes intratumoral vasculature, and prevents metastases in murine Lewis lung carcinoma models when administered at a dose of 30 mg/kg.2,3,4
WARNING This product is not for human or veterinary use.
1. Structure-
2. Metastases and the normalization of tumour blood vessels by ICRF 159: A new type of drug action. Br. Med. J. 1(5800), 597-601 (1972).
3. Histological analysis of the antimetastatic effect of (±)-
4. Dynamics of tumour angiogenesis: Effect of razoxane-